c-mpl Expression in Hematologic Disorders

References

• Whetton A.D., Dexter T.M. Myeloid haematopoietic growth factors. Biochem. Biophys. Acta 1989; 989: 111
   PubMed Web of Science ®Google Scholar
• Whetton A.D., Vallance S.J., Monk P.N., Cragoe E.J., Dexter T.M., Heyworth C.M. Interleukin-3 stimulated haematopoietic stem-cell proliferation. Biochem. J. 1988; 256: 585
   PubMedGoogle Scholar
• Nunez G., London L., Hockenberry D., Alexander M., McKearn J.P., Korshmeyer H. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived haematopoietic cell lines. J. Immunol. 1990; 144: 3602
   PubMed Web of Science ®Google Scholar
• Williams G.T., Smith C.A., Spooncer E., Dexter T.M., Taylor D.R. Haematopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 1990; 343: 76
   PubMed Web of Science ®Google Scholar
• Cosman D., Lyman S.D., Idzerda R.L., Beckman M.P., Park L.S., Goodwin R.G., March C.J. A new cytokine receptor superfamily. Trends Biochem. Sci. 1990; 15: 265
   PubMed Web of Science ®Google Scholar
• Miyajima A., Hara T., Kitamura T. Common subunits of cytokine receptors and the functional redundancy of cytokines. Trends Biochem. Sci. 1992; 17: 378
   PubMed Web of Science ®Google Scholar
• Miyajima A., Mui A. L. F., Ogorochi T., Sakamaki K. Receptors for granulocyte-macrophage colony stimulating factor, interleukin-3, and interleukin-5. Blood 1993; 82: 1960
   PubMed Web of Science ®Google Scholar
• Renaud J.C., Druez C., Kermouni A., Houssiau F., Uyttenhove C., Van Roost E., Van Snick J. Expression cloning of the murine and human interleukin 9 receptor cDNAs. Proc. Natl. Acad. Sci. USA 1992; 89: 5690
   PubMed Web of Science ®Google Scholar
• Vigon I., Momon J.P., Cocault L., Mitjavila M.T., Tambourin P., Gisselbrecht S., Souyri M. Molecular cloning and characterization of h-mpl, a new member of the hematopoietic growth factor receptor superfamily. Proc. Natl. Acad. Sci. USA 1992; 89: 5640
   PubMed Web of Science ®Google Scholar
• Souyri M., Vigon I., Penciolelli J.F., Heard J.M., Tambourin P., Wendling F. A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 1990; 63: 1137
   PubMed Web of Science ®Google Scholar
• Wendling F., Vigon I., Souyri M., Tambourin P. Myeloid progenitor cells transformed by the myeloproliferative leukemia virus proliferate and differentiate in vitro without the addition of growth factors. Leukemia 1989; 3: 475
   PubMed Web of Science ®Google Scholar
• Wendling F., Charon M., Penciolelli J.F., Tambourin P. Factor independent erythropoietic precursor cells in leukemia induced by the myeloproliferative leukemia virus. Blood 1989; 73: 1161
   PubMed Web of Science ®Google Scholar
• Vigon I., Florindo C., Fichelson S., Guenet J.L., Mattei M.G., Souyri M., Cosman D., Gisselbrecht S. Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth. Oncogene 1993; 8: 2607
   PubMed Web of Science ®Google Scholar
• Skoda R.C., Seldin D.C., Chiang M.K., Peichel L., Vogt T.F., Leder P. Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal. EMBOJ. 1993; 12: 2645
   PubMed Web of Science ®Google Scholar
• Le Conniat M., Souyri M., Vigon I., Wendling F., Tambourin P., Berger R. The human homolog of the myeloproliferative virus maps to chromosome band 1p34. Human Genet 1989; 83: 194
   PubMed Web of Science ®Google Scholar
• Methia N., Louache F., Vainchenker W., Wendling F. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoïesis. Blood 1993; 82: 1395
   PubMed Web of Science ®Google Scholar
• Vigon I., Dreyfus F., Melle J., Viguie F., Ribrag V., Cocault L., Souyri M., Gisselbrecht S. Expression of the c-mpl proto-oncogene in human hematologic malignancies. Blood 1993; 82: 877
   PubMed Web of Science ®Google Scholar
• Keating M.J., Cork A., Broach Y., Smith T., Walters R.S., McCredie K.B., Trujillo J., Freireich E.J. Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leuk. Res. 1987; 11: 119
   PubMed Web of Science ®Google Scholar
• Schouten H.C., van Putten W. L. J., Hagemeijer A., Blijham G.H., Sonnenveld P., Willemze R., Slater R., Van de Lely J., Verdonck L., Lowenberg B. The prognostic significance of chromosomal findings in patients with acute myeloid leukemia in a study comparing the efficacy of autologous and allogenic bone marrow transplantation. Bone Marrow Transplant 1991; 8: 377
   PubMed Web of Science ®Google Scholar
• Vaughan W.P., Civin C.I., Weisenburger D.D., Karp J.E., Graham M.L., Sanger W.G., Grierson H.L., Joshi S.S., Burke P.J. Acute leukemia expressing the normal human hematopoietic stem-cell membrane glycoprotein CD34 (MY 10). Leukemia 1988; 2: 261
   PubMedGoogle Scholar
• Geller R.B., Zahurak M., Hurwitz C.A., Burke P.J., Karp J.E., Piantadosi S., Civin C. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (MY10). Br. J. haematol 1990; 76: 340
   PubMed Web of Science ®Google Scholar
• Löwenberg B., Touw P. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993; 81: 281
   PubMed Web of Science ®Google Scholar
• Young D.C., Wagner K., Griffin J.D. Constitutive expression of the granulocyte-macrophage colony stimulating factor gene in acute myeloblastic leukemia. J. Clin. Invest. 1987; 79: 200
   Web of Science ®Google Scholar
• Cheng G. Y. M., Kelleher C.A., Miyauchi J., Wang C., Wong C., Clark S.C., McCulloch E.A., Minden M.D. Structure and expression of genes of GM-CSF and G-CSF in blast cells from patients with acute myeloblastic leukemia. Blood 1988; 71: 35
   Google Scholar
• Cozzolino F., Rubartelli A., Aldinucci D., Sitia R., Torcia M., Shaw A., DiGuglielmo R. Interleukin 1 as an autocrine growth growth factor for acute myeloid leukemia cells. Proc. Natl. Acad. Sci. USA 1989; 86: 2369
   PubMed Web of Science ®Google Scholar
• Lowenberg B., van Putten W. L. J., Touw I.P., Delwel R., Santini V. Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia. New Engl. J. Med 1993; 328: 614
   PubMed Web of Science ®Google Scholar
• Hunter A.E., Rogers S.Y., Roberts I. A. G., Barret A.J., Russell N. Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia. Blood 1993; 82: 899
   PubMed Web of Science ®Google Scholar
• Chang J.M., Metcalf D., Lang R.A., Gonda R.J., Johnson G.R. Non neoplastic hematopoietic myeloproliferative syndrome induced by dysregulated multi-CSF (IL3) expression. Blood 1989; 73: 1487
   PubMed Web of Science ®Google Scholar
• Johnson G.R., Gonda T.J., Metcalf D., Hariharan I.K., Cory S. A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing GM-CSF. EMBO J. 1988; 8: 441
   Web of Science ®Google Scholar
• Yunis J.J., Rydell R.E., Oken M.M., Arnesen M.A., Mayer M.G., Lobel M. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplasia syndromes. Blood 1986; 67: 1721
   PubMed Web of Science ®Google Scholar
• Sullivan S.A., Marsden K.A., Lowenthal R.M., Jupe D.M., Jones M.E. Circulating CD34+ cells: an adverse prognostic factor in the myelodysplastic syndromes. Am. J. Hematol. 1989; 39: 96
   Web of Science ®Google Scholar
• Tricot G., De Wolf Peeters C., Hendrickx B., Verwilghen R.L. Histological finding in myelodysplastic syndromes and comparison with bone marrow smears. Br. J. Haematol. 1984; 57: 423
   PubMed Web of Science ®Google Scholar
• Rios A., Canizo M.C., Sanz M.A., Vallespi T., Sanz G., Torrabadella M., San Miguel J.F. Bone marrow biopsy in myelodysplastic syndromes. Morphological characteristics and contribution to the study of prognostic factors. Br. J. Haematol. 1990; 75: 26
   PubMed Web of Science ®Google Scholar
• Maschek H., Georgii A., Kaloutsi V., Werner M., Bandecar K., Kressel M.G., Choritz H., Freund M., Hufnagl. Myelofibrosis in primary myelodysplastic syndromes: A retrospective study of 352 patients. Eur. J. Haematol. 1992; 48: 208
   PubMed Web of Science ®Google Scholar
• Merchav S., Nielsen O.J., Rosenbaum H., Sharon R., Brenner B., Tatarsky I., Scigalla P., Wieczore T.L. In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes. Leukemia 1990; 4: 771
   PubMed Web of Science ®Google Scholar
• Carlo-Stella C., Cazzola M., Bergamashi G., Bemasconi P., Dezza L., Invernizzi R., Pedrazzoli P. Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor. Leukemia 1989; 3: 363
   PubMed Web of Science ®Google Scholar
• Backx B., Broeders L., Lowenberg B. Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome. Blood 1992; 80: 1213
   PubMed Web of Science ®Google Scholar
• Emmanuel P.D., Bates L.J., Castleberry R.P., Gualtieri R.J., Zuckerman K.S. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 1991; 77: 925
   PubMed Web of Science ®Google Scholar
• Paquette R.L., Landaw E.M., Pierre R.V., Kahan J., Lübbert M., Lazcano O., Isaac G., McCormick F., Koeffler H.P. N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplasia syndromes. Blood 1993; 82: 590
   PubMed Web of Science ®Google Scholar
• Tobal K., Pagliuca A., Bhatt B., Barley N., Layton D.M., Mufti G.J. Mutations of the human FMS gene in myelodysplasia syndromes and acute myeloid leukemia. Leukemia 1990; 4: 486
   PubMed Web of Science ®Google Scholar